Financial & competing interests disclosure
RA Rollins and M Ryskin are employed by Pfizer, and RA Rollins is a Pfizer stockholder. AM Barsotti was previously employed by Pfizer, where he was supported by a fellowship from the Pfizer Worldwide Research and Development Postdoctoral Program. He is currently an employee at Kadmon Pharmaceuticals. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.